Understanding the origins and mechanisms of aryl hydrocarbon receptor promiscuity
了解芳烃受体混杂的起源和机制
基本信息
- 批准号:10679532
- 负责人:
- 金额:$ 51.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-09 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAgonistAllosteric RegulationAmino Acid SequenceAmino AcidsAnimalsAromatic HydrocarbonsAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorBasic ScienceBindingBiological ProcessCell Differentiation processChemicalsChordataCircadian RhythmsDependenceDevelopmentDietary PhytochemicalDioxinsDiseaseDockingEmbryonic DevelopmentEngineeringEnvironmental ExposureEnvironmental PollutantsEnzymesEtiologyEukaryotaEvolutionExposure toFamilyFoundationsGeneticGoalsHelix-Turn-Helix MotifsHematopoiesisHypoxia Inducible FactorImmunityInflammatoryInvertebratesLaboratoriesLigand BindingLigandsMalignant NeoplasmsMediatingModernizationMolecularMutateMutationNPAS4 geneNatural ProductsNuclear ReceptorsOrganPhylogenetic AnalysisPhysiologicalPhysiological ProcessesPhysiologyPlayPolychlorinated BiphenylsProcessPropertyProteinsRegulationResearchRoleSamplingSensitivity and SpecificitySignal TransductionSpecificityStatistical MethodsStructureTestingTetrachlorodibenzodioxinTimeToxic effectTranscriptional ActivationTreesTryptophanVertebratesWorkXenobioticsanthropogenesisaryl hydrocarbon receptor ligandcandidate identificationexposed human populationgut microbiomehalogenationhost microbiomeimmune functioninnovationinsightmembermicrobialmicrobiomemolecular modelingreceptorreceptor functionreconstructionresponsesensorsingle-minded proteintranscription factor
项目摘要
Project Summary/Abstract
The aryl hydrocarbon receptor (AHR) is a bHLH-PAS protein that in vertebrate animals is a ligand-activated
transcription factor that plays essential roles in the regulation of xenobiotic-metabolizing enzymes and in the
mechanisms of toxicity of numerous environmental contaminants, including chlorinated dioxins such as
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), some polychlorinated biphenyls (PCBs), polynuclear aromatic
hydrocarbons (PAHs), and some emerging contaminants. The AHR is also involved in a variety of
physiological processes including development, hematopoiesis, immunity, host-microbiome interactions, and
barrier organ function. In contrast to most ligand-activated transcription factors that have narrow ligand-
specificity, the vertebrate AHR is highly promiscuous, recognizing a diverse array of chemicals. In addition to
the well-known xenobiotics, AHR ligands include dietary phytochemicals, microbiome-derived microbial
metabolites, and endogenous metabolites such as tryptophan catabolites, all of which collectively contribute to
the internal chemical exposome. A comprehensive mechanistic understanding of AHR’s role in the response to
environmental exposures has been hindered by the complexity of its physiological functions and the
bewildering diversity of its ligands. Here, we propose a set of innovative molecular studies to elucidate the
sequence-structure-function determinants of AHR ligand-dependence and the origin of its ligand diversity.
Evidence suggests that the AHR evolved from a ligand-independent (constitutively active) ancestor. The
proposed basic research will experimentally determine the evolutionary trajectory and underlying genetic and
structural mechanisms that drove the evolution of AHR ligand-dependence and promiscuity. In Aim 1, we will
establish the ligand-specificity of AHRs from present-day species through a systematic experimental
assessment of phylogenetically diverse metazoan AHRs, including new invertebrate and early vertebrate
AHRs. In Aim 2, we will use ancestral sequence reconstruction (ASR) to “resurrect” ancestral AHR proteins
and then determine their ligand-binding sensitivity and specificity, revealing the identities of ancestral and
derived ligands. In Aim 3, we will use phylogenetic and protein structural analysis to identify candidate
historical amino acid changes that caused the acquisition of ligand-binding and evolution of promiscuity. We
will test these hypotheses by engineering ancestral and extant proteins containing these substitutions and
experimentally assessing their function. Understanding the ancestral properties of the primordial ligand-
activated AHR and the mechanisms that drove the evolution of promiscuity will provide essential new insights
into the natural physiological ligands and biological functions of extant AHR, reveal the genetic and structural
mechanisms underlying AHR ligand recognition, and elucidate how and why AHR function is disrupted by
anthropogenic environmental contaminants.
项目总结/摘要
芳香烃受体(AHR)是一种bHLH-PAS蛋白,在脊椎动物中是一种配体激活的受体。
一种在外源性物质代谢酶的调节和代谢过程中起重要作用的转录因子。
许多环境污染物的毒性机制,包括氯化二恶英,
2,3,7,8-四氯二苯并对二恶英(TCDD)、某些多氯联苯(PCB)、多核芳香族化合物
碳氢化合物(PAHs)和一些新出现的污染物。AHR还参与了各种
生理过程,包括发育、造血、免疫、宿主-微生物组相互作用,以及
屏障器官功能与大多数配体激活的转录因子相比,
脊椎动物AHR是高度混杂的,识别各种各样的化学物质。除了
众所周知的异生物质、AHR配体包括膳食植物化学物质、微生物组衍生的微生物
代谢物和内源性代谢物如色氨酸催化剂,所有这些共同有助于
内部化学问题。对AHR在应对以下疾病中的作用的全面机制性理解
环境暴露受到其生理功能复杂性的阻碍,
配体的多样性令人眼花缭乱。在这里,我们提出了一套创新的分子研究,以阐明
AHR配体依赖性的序列-结构-功能决定因素及其配体多样性的起源。
有证据表明,AHR是从一个配体独立的(组成型活性)祖先进化而来的。的
拟议的基础研究将通过实验确定进化轨迹和潜在的遗传和
驱动AHR配体依赖性和滥交进化的结构机制。在目标1中,我们
建立配体特异性的AHRs从今天的物种,通过系统的实验
评估遗传多样性后生动物AHR,包括新的无脊椎动物和早期脊椎动物
AHR在目标2中,我们将使用祖先序列重建(ASR)来“复活”祖先AHR蛋白
然后确定它们的配体结合敏感性和特异性,揭示祖先和
衍生配体。在目标3中,我们将使用系统发育和蛋白质结构分析来鉴定候选蛋白质。
导致配体结合获得和滥交进化的历史氨基酸变化。我们
将通过工程改造含有这些取代的祖先和现存蛋白质来测试这些假设,
实验性地评估它们的功能。了解原始配体的祖先特性-
激活的AHR和驱动滥交进化的机制将提供重要的新见解
研究了现存AHR的天然生理配体和生物学功能,揭示了AHR的遗传和结构特征,
AHR配体识别的潜在机制,并阐明如何以及为什么AHR功能被破坏
人为环境污染物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark E Hahn其他文献
Mark E Hahn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark E Hahn', 18)}}的其他基金
Mechanisms Controlling Sensitivity and Resistance to Dioxin-like Compounds: Role of AIP
控制对二恶英类化合物的敏感性和耐受性的机制:AIP 的作用
- 批准号:
10538943 - 财政年份:2022
- 资助金额:
$ 51.1万 - 项目类别:
Gene-by-environment interactions that affect exposure-mediated congenital heart disease
影响暴露介导的先天性心脏病的基因与环境相互作用
- 批准号:
10216463 - 财政年份:2021
- 资助金额:
$ 51.1万 - 项目类别:
Gene-by-environment interactions that affect exposure-mediated congenital heart disease
影响暴露介导的先天性心脏病的基因与环境相互作用
- 批准号:
10655611 - 财政年份:2021
- 资助金额:
$ 51.1万 - 项目类别:
Project 3: Cellular and Molecular Mechanisms Underlying Long-term Effects of Early Life Exposure to HAB Toxins
项目 3:生命早期接触 HAB 毒素造成长期影响的细胞和分子机制
- 批准号:
10434783 - 财政年份:2018
- 资助金额:
$ 51.1万 - 项目类别:
Project 3: Cellular and Molecular Mechanisms Underlying Long-term Effects of Early Life Exposure to HAB Toxins
项目 3:生命早期接触 HAB 毒素造成长期影响的细胞和分子机制
- 批准号:
10223309 - 财政年份:2018
- 资助金额:
$ 51.1万 - 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:
8244524 - 财政年份:2009
- 资助金额:
$ 51.1万 - 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:
8051862 - 财政年份:2009
- 资助金额:
$ 51.1万 - 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:
8450175 - 财政年份:2009
- 资助金额:
$ 51.1万 - 项目类别:
Mechanisms of Embryo Response to Oxidative Stress
胚胎对氧化应激的反应机制
- 批准号:
7655110 - 财政年份:2009
- 资助金额:
$ 51.1万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 51.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 51.1万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 51.1万 - 项目类别:
Grant-in-Aid for Scientific Research (C)